Clearance Summary
LYSIS + received FDA 510(k) clearance under submission number K830186, sponsored by Hematology Marketing Assoc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1983-02-28.
- Submission: K830186
- Applicant / Sponsor: Hematology Marketing Assoc.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class I
- Regulation citation: 21 CFR 864.8540
- Decision date: 1983-02-28
Classification & Regulation
This clearance is catalogued under FDA product code GGK and 21 CFR 864.8540, within the Hematology review panel as a Class I device.